Another Canadian Study Finds an Increased Risk of Bladder Cancer for Those Using Diabetes Drug Actos, the Consumer Justice Foundation Reports

Share Article

The Consumer Justice Foundation, a for-profit corporation staffed by a team of professional consumer advocates who provide free online informational resources to consumers regarding the potential risks and dangers posed by using certain prescription medications, has a Web site URL that is located at http://www.sideeffectsrx.com. The Consumer Justice Foundation hereby alerts the public of another Canadian study regarding the potential risk of developing bladder cancer for those who use the diabetes medication known as Actos.

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provides free online informational resources regarding the potential risks and dangers associated with the use of certain prescription medications, hereby alerts the public of the publication of another study that concludes that using the diabetes drug Actos raises the possibility that patients will develop bladder cancer.

Specifically, this most recent Actos bladder cancer study was published in the July 3 edition of the Canadian Medical Association Journal, and it was headed by Dr. Jeffrey A. Johnson at the Canada Research Chair in Diabetes Health Outcomes at the University Of Alberta School Of Public Health. The study involved researchers analyzing data from 2.6 million people with type 2 diabetes who were prescribed medications from the class known as thiazolidinediones, which includes Actos. The study concluded that 3,643 people within this group were diagnosed with bladder cancer that resulted in an increased risk of Actos users developing bladder cancer by a factor of 22 percent.

This study comes on the heels of another Actos bladder cancer study that was published in the 31 May 2012 Issue of the British Medical Journal. That study was conducted by researchers at McGill University and was entitled, “The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.” That study examined the medical records of more than 115,000 patients who used Actos to treat their diabetes between the years of 1988 and 2009, and it concluded that people who used Actos faced the prospect of developing the Actos side effect of bladder cancer by a factor of 1.99 to 1 when they used the medication for a duration of more than 24 months.

Dr. Johnson, who led the most recent study conducted by Canadian researchers that found an increased risk of bladder cancer in Actos users by a factor of 22 percent stated that he “suspects the link between Actos and bladder cancer would have to be the result of a direct effect of the medication.” Anyone who is using Actos is encouraged to discuss the situation with their doctors.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website